Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Nonmalignant hematology

Nonmalignant hematology editorial memo (2018) 11:165 https://doi.org/10.1007/s12254-018-0424-y Paul N. Knoebl Received: 10 July 2018 / Accepted: 17 July 2018 / Published online: 25 July 2018 © Springer-Verlag GmbH Austria, part of Springer Nature 2018 Esteemed reader, ated with malignant diseases, having been triggered by malignancy or occurring as side effects of anti- MEMO is a journal primarily focusing on medical on- cancer therapy, and special attention is required to cology and hematology, but it is also intended to “of- untangle that network of interactions. This is also true fer a professional review on current research and de- for immune thrombocytopenia, an otherwise rather velopment in the field of hematology and oncology frequent disorder, but challenging when occurring relevant for daily practice”. Under that pretension, in cancer patients. And even variants and abnormal a broader view on aspects not directly associated with forms ofhemoglobin, whichare commoninsome malignancy is encouraged and articles covering topics parts of Europe and are being seen more and more outside of that field have been and will be published frequently in other locations due to increasing mi- in MEMO. gration, can have an impact on the management of In this special issue on nonmalignant hematology cancer patients. Thus, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png memo - Magazine of European Medical Oncology Springer Journals

Nonmalignant hematology

Download PDF
1 page

Nonmalignant hematology

Abstract

editorial memo (2018) 11:165 https://doi.org/10.1007/s12254-018-0424-y Paul N. Knoebl Received: 10 July 2018 / Accepted: 17 July 2018 / Published online: 25 July 2018 © Springer-Verlag GmbH Austria, part of Springer Nature 2018 Esteemed reader, ated with malignant diseases, having been triggered by malignancy or occurring as side effects of anti- MEMO is a journal primarily focusing on medical on- cancer therapy, and special attention is required to cology and hematology, but it is also...
Loading next page...
 
/lp/springer-journals/nonmalignant-hematology-RntqaPOYv7

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer-Verlag GmbH Austria, part of Springer Nature
Subject
Medicine & Public Health; Oncology; Medicine/Public Health, general
ISSN
1865-5041
eISSN
1865-5076
DOI
10.1007/s12254-018-0424-y
Publisher site
See Article on Publisher Site

Abstract

editorial memo (2018) 11:165 https://doi.org/10.1007/s12254-018-0424-y Paul N. Knoebl Received: 10 July 2018 / Accepted: 17 July 2018 / Published online: 25 July 2018 © Springer-Verlag GmbH Austria, part of Springer Nature 2018 Esteemed reader, ated with malignant diseases, having been triggered by malignancy or occurring as side effects of anti- MEMO is a journal primarily focusing on medical on- cancer therapy, and special attention is required to cology and hematology, but it is also intended to “of- untangle that network of interactions. This is also true fer a professional review on current research and de- for immune thrombocytopenia, an otherwise rather velopment in the field of hematology and oncology frequent disorder, but challenging when occurring relevant for daily practice”. Under that pretension, in cancer patients. And even variants and abnormal a broader view on aspects not directly associated with forms ofhemoglobin, whichare commoninsome malignancy is encouraged and articles covering topics parts of Europe and are being seen more and more outside of that field have been and will be published frequently in other locations due to increasing mi- in MEMO. gration, can have an impact on the management of In this special issue on nonmalignant hematology cancer patients. Thus,

Journal

memo - Magazine of European Medical Oncology – Springer Journals

Published: Jul 25, 2018

There are no references for this article.